Page 1

PHILIPS Q3 2021 Philips delivers Q3 sales of EUR 4.2 billion , with a 7.6 % comparable sales decline due to headwinds ; income from continuing operations increases to EUR 442 million , and Adjusted EBITA margin amounts to 12.3 % . Quarterly report Philips sees continued strong demand driving double - digit order intake growth in Q3 . ● Amsterdam , October 18 , 2021 Third - quarter highlights Group sales totaled EUR 4.2 billion , reflecting a 7.6 % comparable sales decline due to headwinds caused by global supply chain challenges and Sleep & Respiratory Care recall consequences Comparable order intake increased 47 % ; order intake increased 17 % excluding the impact of a partial ventilator order cancellation in Q3 2020 • Income from continuing operations increased to EUR 442 million , compared to EUR 279 million in Q3 2020 ● Adjusted EBITA of EUR 512 million , or 12.3 % of sales , compared to EUR 684 million , or 15.5 % of sales , in Q3 2020 Operating cash flow of EUR 256 million , compared to EUR 575 million in Q3 2020 • Domestic Appliances divestment was completed as planned , resulting in a EUR 2.5 billion gain after tax and transaction - related costs ; reported in Discontinued Operations Frans van Houten , CEO " I am pleased with the strong double - digit comparable order intake growth in the third quarter , driven by both the Diagnosis & Treatment businesses and Connected Care businesses . Our strategy and portfolio are highly relevant to our customers , as we help them transform the delivery of care along the health continuum . Building on this strength , we have signed an additional 19 long - term strategic partnerships with hospitals across the world , including a 10 - year partnership with Baptist Health in the US to provide patient monitoring solutions and standardize care across the network . We recorded EUR 4.2 billion sales in the quarter , with a 7.6 % comparable sales decline on the back of 10 % comparable sales growth last year . This quarter's sales were impacted unfavorably by intensified global supply chain issues , such as the shortage of electronic components , and the anticipated revenue consequences of the sleep recall , as we are prioritizing the remediation of affected devices in use by patients . The Adjusted EBITA margin was 12.3 % . The repair and replacement program related to the sleep recall notification is under way in the US and several other markets . I am conscious of the impact this is having on patients and care givers , and we are doing everything we can to deliver a solution as fast as possible . We successfully completed the sale of the Domestic Appliances business , resulting in a gain of EUR 2.5 billion . With this , we concluded our major divestments , allowing us to focus fully on extending our leadership in health technology and continuing our transformation into a solutions company . Quarterly Report 2021 - Q3 1